Perez-Rubio, A.; Flores, R.; Aragon, J.R.; Sanchez, J.; Marquez-Peláez, S.; Alvarez, P.; Muriel, A.O.; Mould-Quevedo, J.
Cost-Effectiveness of Adjuvanted Influenza Vaccine Compared with Standard and High-Dose Influenza Vaccines for Persons Aged ≥50 Years in Spain. Vaccines 2025, 13, 323.
https://doi.org/10.3390/vaccines13030323
AMA Style
Perez-Rubio A, Flores R, Aragon JR, Sanchez J, Marquez-Peláez S, Alvarez P, Muriel AO, Mould-Quevedo J.
Cost-Effectiveness of Adjuvanted Influenza Vaccine Compared with Standard and High-Dose Influenza Vaccines for Persons Aged ≥50 Years in Spain. Vaccines. 2025; 13(3):323.
https://doi.org/10.3390/vaccines13030323
Chicago/Turabian Style
Perez-Rubio, Alberto, Roberto Flores, Jesus Ruiz Aragon, Javier Sanchez, Sergio Marquez-Peláez, Piedad Alvarez, Andres Osorio Muriel, and Joaquin Mould-Quevedo.
2025. "Cost-Effectiveness of Adjuvanted Influenza Vaccine Compared with Standard and High-Dose Influenza Vaccines for Persons Aged ≥50 Years in Spain" Vaccines 13, no. 3: 323.
https://doi.org/10.3390/vaccines13030323
APA Style
Perez-Rubio, A., Flores, R., Aragon, J. R., Sanchez, J., Marquez-Peláez, S., Alvarez, P., Muriel, A. O., & Mould-Quevedo, J.
(2025). Cost-Effectiveness of Adjuvanted Influenza Vaccine Compared with Standard and High-Dose Influenza Vaccines for Persons Aged ≥50 Years in Spain. Vaccines, 13(3), 323.
https://doi.org/10.3390/vaccines13030323
